Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Novo Nordisk A/SADR(NVO) | 691,743 | 741,743 | +50,000 | $98.74M | $88.32M | 24.98% | -$10.42M |
| Eli Lilly and Company(LLY) | 92,593 | 92,593 | 0 | $83.83M | $82.03M | 23.20% | -$1.80M |
| Viking Therapeutics, Inc.(VKTX) | 452,979 | 532,879 | +79,900 | $24.01M | $33.74M | 9.54% | +$9.72M |
| Intra-Cellular Therapies Inc | 216,519 | 216,519 | 0 | $14.83M | $15.84M | 4.48% | +$1.01M |
| AstraZeneca PLCADR(AZN) | 190,752 | 190,752 | 0 | $14.88M | $14.86M | 4.20% | -$15.3K |
| Soleno Therapeutics Inc | 94,424 | 274,424 | +180,000 | $3.85M | $13.86M | 3.92% | +$10.00M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 35,000 | 35,000 | 0 | $8.51M | $9.63M | 2.72% | +$1.12M |
| Vertex Pharmaceuticals Incorporated(VRTX) | 18,900 | 18,900 | 0 | $8.86M | $8.79M | 2.49% | -$68.8K |
| Vaxcyte, Inc.(PCVX) | 76,255 | 76,255 | 0 | $5.76M | $8.71M | 2.46% | +$2.96M |
| argenx SEADR(ARGX) | 15,138 | 15,138 | 0 | $6.51M | $8.21M | 2.32% | +$1.70M |
| Axsome Therapeutics, Inc.(AXSM) | 87,848 | 87,848 | 0 | $7.07M | $7.89M | 2.23% | +$823.1K |
| Protagonist Therapeutics Inc | 124,440 | 124,440 | 0 | $4.31M | $5.60M | 1.58% | +$1.29M |
| Neurocrine Biosciences, Inc.(NBIX) | 45,000 | 45,000 | 0 | $6.20M | $5.18M | 1.47% | -$1.01M |
| Revolution Medicines, Inc.(RVMD) | 0 | 95,885 | +95,885 | $0 | $4.35M | 1.23% | +$4.35M |
| Dyne Therapeutics, Inc.(DYN) | 119,488 | 119,488 | 0 | $4.22M | $4.29M | 1.21% | +$75.3K |
| Verona Pharma PlcADS | 130,790 | 148,590 | +17,800 | $1.89M | $4.27M | 1.21% | +$2.38M |
| Merus N V | 50,171 | 80,171 | +30,000 | $2.97M | $4.01M | 1.13% | +$1.04M |
| Insmed Incorporated(INSM) | 53,436 | 52,939 | -497 | $3.58M | $3.86M | 1.09% | +$284.3K |
| Celldex Therapeutics, Inc.(CLDX) | 75,300 | 75,300 | 0 | $2.79M | $2.56M | 0.72% | -$227.4K |
| Crinetics Pharmaceuticals In | 85,765 | 45,765 | -40,000 | $3.84M | $2.34M | 0.66% | -$1.50M |
| IDEAYA Biosciences, Inc.(IDYA) | 54,392 | 62,992 | +8,600 | $1.91M | $2.00M | 0.56% | +$85.9K |
| Mereo BioPharma Group plcADS(MREO) | 421,359 | 421,359 | 0 | $1.52M | $1.73M | 0.49% | +$214.9K |
| Springworks Therapeutics Inc | 53,930 | 53,930 | 0 | $2.03M | $1.73M | 0.49% | -$303.6K |
| Nuvalent Inc | 0 | 15,437 | +15,437 | $0 | $1.58M | 0.45% | +$1.58M |
| Xenon Pharmaceuticals Inc.(XENE) | 40,000 | 40,000 | 0 | $1.56M | $1.57M | 0.45% | +$15.2K |
| Centessa Pharmaceuticals PlcADS | 0 | 80,380 | +80,380 | $0 | $1.29M | 0.36% | +$1.29M |
| EyePoint, Inc.(EYPT) | 101,500 | 156,300 | +54,800 | $883.0K | $1.25M | 0.35% | +$365.8K |
| Charles River Laboratories International, Inc.(CRL) | 6,905 | 6,305 | -600 | $1.43M | $1.24M | 0.35% | -$184.5K |
| Ionis Pharmaceuticals, Inc.(IONS) | 62,479 | 30,479 | -32,000 | $2.98M | $1.22M | 0.35% | -$1.76M |
| Keros Therapeutics, Inc.(KROS) | 20,000 | 20,000 | 0 | $914.0K | $1.16M | 0.33% | +$247.4K |
| Kura Oncology, Inc.(KURA) | 57,178 | 57,178 | 0 | $1.18M | $1.12M | 0.32% | -$60.0K |
| Ascendis Pharma A/SADR(ASND) | 7,440 | 7,440 | 0 | $1.01M | $1.11M | 0.31% | +$96.2K |
| Annexon, Inc.(ANNX) | 147,485 | 172,226 | +24,741 | $722.7K | $1.02M | 0.29% | +$296.9K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 20,000 | 47,400 | +27,400 | $905.0K | $977.9K | 0.28% | +$72.9K |
| Silence Therapeutics plcADS(SLN) | 52,476 | 52,476 | 0 | $997.0K | $954.0K | 0.27% | -$43.0K |
| Syndax Pharmaceuticals, Inc.(SNDX) | 48,263 | 48,263 | 0 | $990.8K | $929.1K | 0.26% | -$61.8K |
| Newamsterdam Pharma Company ORDINARY SHARES | 54,285 | 54,285 | 0 | $1.04M | $901.1K | 0.25% | -$141.7K |
| Alector Inc | 0 | 193,317 | +193,317 | $0 | $900.9K | 0.25% | +$900.9K |
| Disc Medicine, Inc.(IRON) | 13,440 | 13,440 | 0 | $605.7K | $660.4K | 0.19% | +$54.7K |
| Larimar Therapeutics, Inc.(LRMR) | 90,490 | 90,490 | 0 | $656.1K | $592.7K | 0.17% | -$63.3K |
| Acelyrin Inc | 0 | 93,114 | +93,114 | $0 | $459.1K | 0.13% | +$459.1K |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 1,557 | 1,557 | 0 | $436.2K | $330.4K | 0.09% | -$105.8K |
| Summit Therapeutics Inc.(SMMT) | 0 | 14,512 | +14,512 | $0 | $317.8K | 0.09% | +$317.8K |
| Q32 Bio Inc.(QTTB) | 0 | 4,705 | +4,705 | $0 | $209.9K | 0.06% | +$209.9K |
| Apogee Therapeutics Inc | 58,400 | 0 | -58,400 | $2.30M | $0 | — | -$2.30M |
| Merck & Co., Inc.(MRK) | 442,504 | 0 | -442,504 | $54.78M | $0 | — | -$54.78M |
| Ocular Therapeutix, Inc.(OCUL) | 500,000 | 0 | -500,000 | $3.42M | $0 | — | -$3.42M |
| Pliant Therapeutics, Inc.(PLRX) | 50,000 | 0 | -50,000 | $537.5K | $0 | — | -$537.5K |
| Sarepta Therapeutics, Inc.(SRPT) | 2,600 | 0 | -2,600 | $410.8K | $0 | — | -$410.8K |